These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35211839)

  • 1. Compulsory vaccination against COVID-19: a legal and ethical perspective on public good versus personal reticence.
    Dunne CP; Spain E
    Ir J Med Sci; 2023 Feb; 192(1):221-226. PubMed ID: 35211839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
    Lundberg L; Bygdell M; Stukat von Feilitzen G; Woxenius S; Ohlsson C; Kindblom JM; Leach S
    Vaccine; 2021 Jul; 39(32):4414-4418. PubMed ID: 34187707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.
    Glasser JW; Feng Z; Omer SB; Smith PJ; Rodewald LE
    Lancet Infect Dis; 2016 May; 16(5):599-605. PubMed ID: 26852723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herd immunity, vaccination and moral obligation.
    Bullen M; Heriot GS; Jamrozik E
    J Med Ethics; 2023 Sep; 49(9):636-641. PubMed ID: 37277175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic.
    da Silva TMR; de Sá ACMGN; Vieira EWR; Prates EJS; Beinner MA; Matozinhos FP
    BMC Infect Dis; 2021 Dec; 21(1):1237. PubMed ID: 34886804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some issues of compulsory vaccination of adults.
    Vlček V
    Cent Eur J Public Health; 2024 Jun; 32(2):132-136. PubMed ID: 39069317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees.
    Ezeji-Okoye S; Bilodeau BL; Madhusudhan DK; Pruett E; Thokala S; Bravata DM
    J Prim Care Community Health; 2021; 12():21501327211005902. PubMed ID: 33813919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020.
    McDonald HI; Tessier E; White JM; Woodruff M; Knowles C; Bates C; Parry J; Walker JL; Scott JA; Smeeth L; Yarwood J; Ramsay M; Edelstein M
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Compulsory Vaccination: An Acceptable Form of Coercion?
    Hurford JE
    New Bioeth; 2022 Mar; 28(1):4-26. PubMed ID: 34906027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course.
    Larenas-Linnemann DE; Rodríguez-Monroy F
    Allergy; 2021 Mar; 76(3):910-914. PubMed ID: 32894782
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.
    Gold JE; Baumgartl WH; Okyay RA; Licht WE; Fidel PL; Noverr MC; Tilley LP; Hurley DJ; Rada B; Ashford JW
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compulsory vaccination against COVID-19 in the context of the principles of the convention on human rights and biomedicine.
    Hristozova MV; Semerdjieva MA; Mavrov MS; Bakova DR
    Folia Med (Plovdiv); 2023 Feb; 65(1):111-115. PubMed ID: 36855982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-19: Would compulsory vaccination be legally possible?].
    Frielitz FS; Wagner IV; Schewe DM; Bothe K
    Dtsch Med Wochenschr; 2021 Feb; 146(3):206-208. PubMed ID: 33440433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity and Vaccination Against Measles, Mumps, and Rubella in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Kawamura K; Wada H; Nakasone H; Akahoshi Y; Kawamura S; Takeshita J; Yoshino N; Misaki Y; Yoshimura K; Gomyo A; Tamaki M; Kusuda M; Kameda K; Sato M; Tanihara A; Kimura SI; Kako S; Kanda Y
    Transplant Cell Ther; 2021 May; 27(5):436.e1-436.e8. PubMed ID: 33775586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines.
    Oygar PD; Büyükçam A; Sahbudak Bal Z; Dalgıç N; Bozdemir ŞE; Karbuz A; Çetin BŞ; Kara Y; Çetin C; Hatipoğlu N; Uygun H; Aygün FD; Hançerli Törün S; Şener Okur D; Yılmaz Çiftdoğan D; Tural Kara T; Yahşi A; Özer A; Öcal Demir S; Akkoç G; Turan C; Salı E; Şen S; Erdeniz EH; Kara SS; Emiroğlu M; Erat T; Aktürk H; Laçinel Gürlevik S; Sütçü M; Gayretli Aydın ZG; Yıldız Atikan B; Yeşil E; Güner Özenen G; Çelebi E; Efe K; Kizmaz Isancli D; Selver Durmuş H; Tekeli S; Karaaslan A; Bülbül L; Almış H; Kaba Ö; Ekemen Keleş Y; Yazıcıoğlu B; Bahtiyar Oğuz S; Ovalı HF; Doğan HH; Çelebi S; Çakir D; Karasulu B; Alkan G; Yenidoğan İ; Gül D; Parıltan Kücükalioğlu B; Avcu G; Kukul MG; Bilen M; Yaşar B; Üstün T; Kılıç Ö; Akın Y; Oral Cebeci S; Bucak İH; Sarı Yanartaş M; Şahin A; Arslanoglu S; Elevli M; Çoban R; Tuter Öz SK; Hatipoğlu H; Erkum İT; Turgut M; Demirbuğa A; Özçelik T; Çiftçi D; Sarı EE; Akkuş G; Hatipoğlu SS; Dinleyici EC; Hacimustafaoğlu M; Özkınay F; Kurugöl Z; Cengiz AB; Somer A; Tezer H; Kara A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2044707. PubMed ID: 35714279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.